Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
McLoughlin Margaret
Director at Quince Therapeutics. Filing since 13 May 2019.
CIK 0001770823
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX
Quince Therapeutics, Inc.
8 Aug 2023
Director
Bought
8,000
$9.84K
opened
QNCX
Quince Therapeutics, Inc.
8 Oct 2021
Director
Sold, plan not stated
1,000
$88.93K
100%
QNCX
Quince Therapeutics, Inc.
16 Aug 2021
Director
Sold, plan not stated
6,000
$572.64K
100%
QNCX
Quince Therapeutics, Inc.
28 Jun 2021
Director
Sold, plan not stated
550
$30.33K
100%
QNCX
Quince Therapeutics, Inc.
13 May 2019
Director
Bought
550
$9.35K
opened
5 decisions on file.
